EP1083983B1 - Dosing apparatus and method for continuous injection of a preferably small amount of secondary sterile liquid into a free-flowing primary component of sterile liquid - Google Patents
Dosing apparatus and method for continuous injection of a preferably small amount of secondary sterile liquid into a free-flowing primary component of sterile liquid Download PDFInfo
- Publication number
- EP1083983B1 EP1083983B1 EP99927045A EP99927045A EP1083983B1 EP 1083983 B1 EP1083983 B1 EP 1083983B1 EP 99927045 A EP99927045 A EP 99927045A EP 99927045 A EP99927045 A EP 99927045A EP 1083983 B1 EP1083983 B1 EP 1083983B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- dosing apparatus
- inner part
- liquid
- protective wafer
- sterile liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
- B01F23/40—Mixing liquids with liquids; Emulsifying
- B01F23/45—Mixing liquids with liquids; Emulsifying using flow mixing
- B01F23/451—Mixing liquids with liquids; Emulsifying using flow mixing by injecting one liquid into another
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F25/00—Flow mixers; Mixers for falling materials, e.g. solid particles
- B01F25/30—Injector mixers
- B01F25/31—Injector mixers in conduits or tubes through which the main component flows
- B01F25/314—Injector mixers in conduits or tubes through which the main component flows wherein additional components are introduced at the circumference of the conduit
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F33/00—Other mixers; Mixing plants; Combinations of mixers
- B01F33/50—Movable or transportable mixing devices or plants
- B01F33/501—Movable mixing devices, i.e. readily shifted or displaced from one place to another, e.g. portable during use
- B01F33/5011—Movable mixing devices, i.e. readily shifted or displaced from one place to another, e.g. portable during use portable during use, e.g. hand-held
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F35/00—Accessories for mixers; Auxiliary operations or auxiliary devices; Parts or details of general application
- B01F35/10—Maintenance of mixers
- B01F35/145—Washing or cleaning mixers not provided for in other groups in this subclass; Inhibiting build-up of material on machine parts using other means
- B01F35/1452—Washing or cleaning mixers not provided for in other groups in this subclass; Inhibiting build-up of material on machine parts using other means using fluids
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F35/00—Accessories for mixers; Auxiliary operations or auxiliary devices; Parts or details of general application
- B01F35/71—Feed mechanisms
- B01F35/713—Feed mechanisms comprising breaking packages or parts thereof, e.g. piercing or opening sealing elements between compartments or cartridges
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F35/00—Accessories for mixers; Auxiliary operations or auxiliary devices; Parts or details of general application
- B01F35/71—Feed mechanisms
- B01F35/713—Feed mechanisms comprising breaking packages or parts thereof, e.g. piercing or opening sealing elements between compartments or cartridges
- B01F35/7137—Piercing, perforating or melting membranes or closures which seal the compartments
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F35/00—Accessories for mixers; Auxiliary operations or auxiliary devices; Parts or details of general application
- B01F35/71—Feed mechanisms
- B01F35/717—Feed mechanisms characterised by the means for feeding the components to the mixer
- B01F35/71805—Feed mechanisms characterised by the means for feeding the components to the mixer using valves, gates, orifices or openings
- B01F35/718051—Feed mechanisms characterised by the means for feeding the components to the mixer using valves, gates, orifices or openings being adjustable
Definitions
- the present invention relates to a dosing apparatus and a method for injection of a preferably small amount of secondary sterile liquid into a free-flowing primary component of sterile liquid.
- the secondary component liquid (or liquids) consists of added volumes which are 0.05-10% of the volume of the primary liquid, and the added volume of secondary liquid in the completed packages are only allowed to vary to a very small degree, of course depending on the intended use of the liquid.
- the variables are generally very small whereas in food technology it is possible to apply slightly greater variations such as 5%.
- a previously filed patent application concerning adding of small quantities of liquid to a flowing liquid is, for instance, Swedish Patent Application No. 9602179-5.
- the invention relates to the way in which this should be done under aseptic conditions.
- the invention concerns the way of mixing sterile liquids with each other and packaging in a prior art manner the mixed liquid in aseptic containers. It is true that the invention is not completely directed to the liquids being uniform in respect of volume, but the practical applications that have been made have, however, been limited in such manner that the invention concerns the way in which 0.05-10% of a secondary liquid can be mixed with a primary liquid, thus enabling the result to be a closed package with a volume accuracy as intended, the mixed liquids supplied to the package being sterile.
- liquids can be sterilised and handled in a way that maintains sterility. It is also known that such sterile liquid can be mixed in tanks and that the contents of these tanks can later be discharged and poured into packages. However, it has been found difficult to carry out these methods. They further necessitate large storage spaces and long mixing periods for the materials. However, by means of new packaging machines, for instance those sold by Tetra Pak AB under the trademark Tetra Brik, it is possible to continuously mix and package liquid material, such as liquids, in consumer packages.
- Such packaging machines can be intended for the manufacture of aseptic packages, and with a view to obtaining such an aseptic package containing several liquids, the liquids must be mixed in a preparatory operation during the transport of the sterile liquid material from their storage to the packaging machine, thereby achieving a liquid mixture which is correct in terms of volume.
- examples of such products are juice or milk products, but it is worth noticing, and has already been pointed out, that the invention can also be used for medical products, cleaning products etc.
- the dosing apparatus according to invention disclosed in claim 1 is characterised in that the dosing apparatus for the product that is to be packaged has a controllable valve with a movable closing sleeve for controlling the supply of secondary liquid to the flowing primary liquid, that the dosing apparatus has an outer valve member which in itself comprises an inner part which is displaceable in relation to the valve member and has a recess or duct whose end facing the closing sleeve is covered with a sealing protective wafer, that a supply tube for supplying secondary sterile liquid is arranged in said recess or duct, and that the dosing apparatus has a means for rupturing the protective wafer to allow injection of the secondary sterile liquid into the primary sterile liquid through the supply tube.
- Embodiments of the invention, or more precisely of the inventive dosing apparatus, will be described below and are disclosed in the dependent claims 2-9. It is possible to use the dosing apparatus for many other packaging machines than the above-mentioned Tetra Pak machine, which is only mentioned as an example of a suitable packaging machine, and it should be emphasised that the invention constitutes a suitable dosing valve for adding a sterile secondary liquid in the cases where mixing is to be carried out while the sterile liquids are being transported to the packaging machine and a well functioning mixing and an accurate mixing between the liquids are desirable.
- Figs 1-6 illustrate the dosing apparatus in cross-section and how the apparatus is operated in the initial position and the shut-off position.
- Fig. 1 shows how a primary conduit 1 is sterilised with vapour or gas.
- a first embodiment of the dosing apparatus is connected to the primary conduit 1.
- a closing sleeve or closing valve 16 of the dosing apparatus is open.
- An inner part of the dosing apparatus is raised to its upper position and covered with a protective wafer 8.
- Fig. 2 shows how a valve member 18 of the dosing apparatus in Fig. 1 is internally sterilised with the closing sleeve 16 in its closed position and the inner part 17 lowered under the position of a groove 5.
- a sterilising agent preferably in the form of a liquid, is supplied through connecting tubes 4.
- Fig. 3 shows the dosing apparatus in Fig. 1 in its operating position.
- the closing sleeve 16 is raised and the inner part 17 is returned to its upper position.
- a longitudinally adjustable supply tube 12 is raised so that its front edge has penetrated the wafer 8, which means that secondary liquids discharged through the supply tube 12 are being mixed with the primary liquid in the primary conduit 1.
- Fig. 4 shows how the dosing apparatus in Fig. 1 can be quickly shut off by the closing sleeve 16 closing the contact between the dosing apparatus and the primary conduit 1.
- Fig 5 a-c illustrate a connecting device for connecting the invention.
- Fig. 6 shows a second embodiment of the inventive dosing apparatus.
- the described apparatus can be used to mix and package liquids intended to be packaged in an aseptic packaging machine, for instance of the type sold under the trademark Tetra Brik.
- the liquids have been produced and sterilised in advance in some suitable manner and packaged or stored in aseptic storage tanks.
- One or more of the dosing apparatus according to the invention are connected in the pipe connection between the aseptic storage tanks and the packaging machine.
- the connection is arranged in such manner that a dominating primary liquid is to be mixed with a secondary liquid whose volume in the mixture should be 0.05 to 10% of the total volume, but the mixing ratio should be constant in the packages produced.
- this is achieved by measuring the flowing amount of primary liquid and letting the result of this measurement essentially control the supply of the secondary liquid so that the added amount of secondary liquid is always controlled by the amount of pumped primary liquid.
- the two mixed liquids have been sterilised and they are to be mixed and packaged in an aseptic packaging machine without their sterility being lost.
- FIGs 1-5 illustrate the dosing apparatus according to a first preferred embodiment of the invention. With a view to elucidating the description, the dosing apparatus is shown in section.
- the dosing apparatus is presented in its static design and the conduit, below referred to as primary conduit, for the primary liquid is designated 1.
- a seat for the dosing apparatus which essentially has two parts, viz. an upper movable closing sleeve 16 which is arranged to be moved upwards and downwards and be pressed against the upper part of the valve member 18 fixed in the primary conduit 1, the pressing being carried out by means of packing rings 2 mounted on the closing sleeve 16.
- the lower part of the dosing apparatus comprises the valve member 18 which has an inner cylindrical wall and a circumferential groove or annular gap 5, which is connected to connecting tubes 4, through which a sterilising material can be supplied.
- An inner part 17 is inserted into the cylindrical interior of the valve member 18.
- the inner part 17 has a central bore or duct 19, which at the top is covered with a rupturable protective wafer 8.
- the inner part 17 also has two spaced-apart packing rings 6, which in the upper position of the inner part 17 surround and seal the circumferential groove 5 of the valve member 18.
- a supply tube 12 is arranged in the central duct 19 of the inner part 17.
- the supply tube 12 is movable in relation to the inner part 17 but also connected so as to accompany the inner part 17 as this is moved back and forth.
- the inner part 17 is moved by means of the guiding lug 7 while the supply tube 12 is displaced separately by means of the guiding lug 15.
- the lower portion of the inner part 17 is sealingly connected with a folded connecting means or bellows 11 which can be moved without the tightness of the system being lost.
- the folded connecting means 11 is kept in its position by the guiding lug 7, which can be moved up or down with the aid of means (not shown). As is evident from Fig. 5, the lower part of the folded connecting means 11 is fixed in a holder 14, which also holds the supply tube 12. The supply tube 12 can be raised with the aid of a further guide means 22 to a position above the protective wafer 8, which is then ruptured by the cutting edge 20 of the tube to form an opening 9.
- the protective wafers 8 must have certain features. They must not be too easily rupturable and they must withstand high temperatures as well as high pressures. As far as our experience goes, the wafer material should be plastic or rubber and the wafers should withstand a temperature of 140°C at an excess pressure of 2 bar.
- Fig 1 shows how the dosing apparatus is connected in the primary conduit 1 which extends between a storage tank (not shown) for the primary liquid and the packaging machine (not shown).
- the closing sleeve 16 is raised and the lower part of the dosing apparatus is protected by the wafer 8.
- the primary conduit 1 is flushed with a hot sterilising liquid or with some sterilising gas so as to make the primary conduit 1 sterile and maintain its sterility.
- the closing sleeve 16 is closed, whereupon the inner part 17 is pulled backwards with the aid of said means 7 so that a free volume forms in the upper part of the valve member 18. Since in this position the circumferential groove 5 is uncovered, the upper part of the valve member 18 is sterilised together with the circumferential groove 5 by using a sterilising agent in the form of liquid or gas supplied through the connecting tubes 4.
- the closing sleeve 16 is again raised and the inner part 17 is once more in its upper position.
- the position of the supply tube 12 is raised so that the cutting edge 20 of the tube 12 ruptures the protective wafer 8.
- the apparatus is now ready to be used and the primary liquid is supplied through the primary conduit 1 while at the same time feeding the previously mentioned secondary liquid, which is controlled by the flowing amount of the primary liquid.
- Fig. 4 shows how the apparatus is stopped without sterility being lost. The stopping occurs simply by the closing sleeve 16 being lowered towards the valve member 18 so that the supply of secondary and primary liquid is stopped. In this manner, the apparatus can be switched off for a long period without necessitating the starting of a new sterilising programme.
- Fig. 5 shows how the connecting devices to the dosing apparatus can be arranged.
- Fig. a) shows the connecting device before being fixed on the dosing apparatus.
- the inner part 17 with its applied protective wafer 8 and its packing rings 6 has already been described. It is evident from the Figure that the inner part 17 with the supply tube 12 can be connected, by means of a screw connection 23, to a distribution tube 25 whose opposite end can also have a tight protective wafer to be connected to a sterile tank for secondary liquid.
- Fig. b) shows a smaller type of connecting device intended to be used when adding very small amounts of secondary liquid
- Fig. c) shows protective sleeves which can be used to cover the contact surfaces of the not yet used connecting means.
- the distribution tube 25 can, before the sterilising treatment, be packaged in a sealed plastic bag, but as a rule it is sufficient to use the protective sleeves 10 shown in Fig. 5 as an aseptic seal of the distribution tube 25.
- Fig. 6 shows a second preferred embodiment of the dosing apparatus according to the invention. What differs this embodiment from the above first embodiment of the present invention is that the means for rupturing the protective wafer 8 in this case consists of a projection 24 arranged on the closing sleeve 16.
- the projection 24 is made to engage the protective wafer 8 and, thus, penetrate the same.
- the supply tube 12 can then be inserted through the thus formed opening 9 to allow injection of the secondary sterile liquid into the primary sterile liquid flowing in the primary conduit 1.
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- External Artificial Organs (AREA)
- Application Of Or Painting With Fluid Materials (AREA)
- Supply Of Fluid Materials To The Packaging Location (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
- The present invention relates to a dosing apparatus and a method for injection of a preferably small amount of secondary sterile liquid into a free-flowing primary component of sterile liquid.
- In the cases where two or more liquids are to be mixed and the mixed liquid volume must have a certain composition in respect of the volume of the liquids included, there are already inventions relating to the way in which a secondary liquid is added to a primary liquid which is conducted in a tube. Without separate mixing in a vessel, the liquids must be passed from their storage containers up to the packaging machine and, while being transported, they must be mixed with great accuracy so that none of the manufactured packages have too large or too small an amount of added liquids. As a rule, this is a problem particularly when adding exceedingly small amounts of a secondary liquid to a considerably larger volume of primary liquid. In the case here described, the secondary component liquid (or liquids) consists of added volumes which are 0.05-10% of the volume of the primary liquid, and the added volume of secondary liquid in the completed packages are only allowed to vary to a very small degree, of course depending on the intended use of the liquid. In medical technology the variables are generally very small whereas in food technology it is possible to apply slightly greater variations such as 5%. A previously filed patent application concerning adding of small quantities of liquid to a flowing liquid is, for instance, Swedish Patent Application No. 9602179-5.
- In the present case, the requirement that a small amount of secondary liquid be mixed with another liquid is not involved, but the invention relates to the way in which this should be done under aseptic conditions. Thus the invention concerns the way of mixing sterile liquids with each other and packaging in a prior art manner the mixed liquid in aseptic containers. It is true that the invention is not completely directed to the liquids being uniform in respect of volume, but the practical applications that have been made have, however, been limited in such manner that the invention concerns the way in which 0.05-10% of a secondary liquid can be mixed with a primary liquid, thus enabling the result to be a closed package with a volume accuracy as intended, the mixed liquids supplied to the package being sterile.
- As mentioned above, it is quite obvious that liquids can be sterilised and handled in a way that maintains sterility. It is also known that such sterile liquid can be mixed in tanks and that the contents of these tanks can later be discharged and poured into packages. However, it has been found difficult to carry out these methods. They further necessitate large storage spaces and long mixing periods for the materials. However, by means of new packaging machines, for instance those sold by Tetra Pak AB under the trademark Tetra Brik, it is possible to continuously mix and package liquid material, such as liquids, in consumer packages. Such packaging machines can be intended for the manufacture of aseptic packages, and with a view to obtaining such an aseptic package containing several liquids, the liquids must be mixed in a preparatory operation during the transport of the sterile liquid material from their storage to the packaging machine, thereby achieving a liquid mixture which is correct in terms of volume. Examples of such products are juice or milk products, but it is worth noticing, and has already been pointed out, that the invention can also be used for medical products, cleaning products etc.
- The dosing apparatus according to invention disclosed in claim 1 is characterised in that the dosing apparatus for the product that is to be packaged has a controllable valve with a movable closing sleeve for controlling the supply of secondary liquid to the flowing primary liquid, that the dosing apparatus has an outer valve member which in itself comprises an inner part which is displaceable in relation to the valve member and has a recess or duct whose end facing the closing sleeve is covered with a sealing protective wafer, that a supply tube for supplying secondary sterile liquid is arranged in said recess or duct, and that the dosing apparatus has a means for rupturing the protective wafer to allow injection of the secondary sterile liquid into the primary sterile liquid through the supply tube.
- The method according to the invention is disclosed in
claim 10. - Embodiments of the invention, or more precisely of the inventive dosing apparatus, will be described below and are disclosed in the dependent claims 2-9. It is possible to use the dosing apparatus for many other packaging machines than the above-mentioned Tetra Pak machine, which is only mentioned as an example of a suitable packaging machine, and it should be emphasised that the invention constitutes a suitable dosing valve for adding a sterile secondary liquid in the cases where mixing is to be carried out while the sterile liquids are being transported to the packaging machine and a well functioning mixing and an accurate mixing between the liquids are desirable.
- In the following description of two different embodiments of the invention, Figs 1-6 illustrate the dosing apparatus in cross-section and how the apparatus is operated in the initial position and the shut-off position.
- Fig. 1 shows how a primary conduit 1 is sterilised with vapour or gas. A first embodiment of the dosing apparatus is connected to the primary conduit 1. A closing sleeve or
closing valve 16 of the dosing apparatus is open. An inner part of the dosing apparatus is raised to its upper position and covered with aprotective wafer 8. - Fig. 2 shows how a
valve member 18 of the dosing apparatus in Fig. 1 is internally sterilised with theclosing sleeve 16 in its closed position and theinner part 17 lowered under the position of agroove 5. A sterilising agent, preferably in the form of a liquid, is supplied through connectingtubes 4. - Fig. 3 shows the dosing apparatus in Fig. 1 in its operating position. The
closing sleeve 16 is raised and theinner part 17 is returned to its upper position. A longitudinallyadjustable supply tube 12 is raised so that its front edge has penetrated thewafer 8, which means that secondary liquids discharged through thesupply tube 12 are being mixed with the primary liquid in the primary conduit 1. - Fig. 4 shows how the dosing apparatus in Fig. 1 can be quickly shut off by the
closing sleeve 16 closing the contact between the dosing apparatus and the primary conduit 1. - Fig 5 a-c illustrate a connecting device for connecting the invention.
- Fig. 6 shows a second embodiment of the inventive dosing apparatus.
- Special embodiments of the invention will be described below by means of the accompanying drawings. It is worth noticing that the invention can be used with other types of connecting devices or dosing apparatus if these connecting devices satisfy the features as defined in the claims.
- As mentioned above, the described apparatus can be used to mix and package liquids intended to be packaged in an aseptic packaging machine, for instance of the type sold under the trademark Tetra Brik. The liquids have been produced and sterilised in advance in some suitable manner and packaged or stored in aseptic storage tanks. One or more of the dosing apparatus according to the invention are connected in the pipe connection between the aseptic storage tanks and the packaging machine. As emphasised above, the connection is arranged in such manner that a dominating primary liquid is to be mixed with a secondary liquid whose volume in the mixture should be 0.05 to 10% of the total volume, but the mixing ratio should be constant in the packages produced. As is apparent from a previously filed patent application, this is achieved by measuring the flowing amount of primary liquid and letting the result of this measurement essentially control the supply of the secondary liquid so that the added amount of secondary liquid is always controlled by the amount of pumped primary liquid.
- In the present case, the two mixed liquids have been sterilised and they are to be mixed and packaged in an aseptic packaging machine without their sterility being lost.
- The enclosed Figs 1-5 illustrate the dosing apparatus according to a first preferred embodiment of the invention. With a view to elucidating the description, the dosing apparatus is shown in section.
- First, the dosing apparatus is presented in its static design and the conduit, below referred to as primary conduit, for the primary liquid is designated 1. In the primary conduit 1 there is arranged a seat for the dosing apparatus which essentially has two parts, viz. an upper
movable closing sleeve 16 which is arranged to be moved upwards and downwards and be pressed against the upper part of thevalve member 18 fixed in the primary conduit 1, the pressing being carried out by means ofpacking rings 2 mounted on theclosing sleeve 16. The lower part of the dosing apparatus comprises thevalve member 18 which has an inner cylindrical wall and a circumferential groove orannular gap 5, which is connected to connectingtubes 4, through which a sterilising material can be supplied. Aninner part 17 is inserted into the cylindrical interior of thevalve member 18. Theinner part 17 has a central bore orduct 19, which at the top is covered with a rupturableprotective wafer 8. Theinner part 17 also has two spaced-apart packing rings 6, which in the upper position of theinner part 17 surround and seal thecircumferential groove 5 of thevalve member 18. Asupply tube 12 is arranged in thecentral duct 19 of theinner part 17. Thesupply tube 12 is movable in relation to theinner part 17 but also connected so as to accompany theinner part 17 as this is moved back and forth. Theinner part 17 is moved by means of the guiding lug 7 while thesupply tube 12 is displaced separately by means of the guidinglug 15. The lower portion of theinner part 17 is sealingly connected with a folded connecting means orbellows 11 which can be moved without the tightness of the system being lost. The foldedconnecting means 11 is kept in its position by the guiding lug 7, which can be moved up or down with the aid of means (not shown). As is evident from Fig. 5, the lower part of the foldedconnecting means 11 is fixed in aholder 14, which also holds thesupply tube 12. Thesupply tube 12 can be raised with the aid of a further guide means 22 to a position above theprotective wafer 8, which is then ruptured by thecutting edge 20 of the tube to form an opening 9. - The
protective wafers 8 must have certain features. They must not be too easily rupturable and they must withstand high temperatures as well as high pressures. As far as our experience goes, the wafer material should be plastic or rubber and the wafers should withstand a temperature of 140°C at an excess pressure of 2 bar. - Fig 1 shows how the dosing apparatus is connected in the primary conduit 1 which extends between a storage tank (not shown) for the primary liquid and the packaging machine (not shown). As shown in the figure, the
closing sleeve 16 is raised and the lower part of the dosing apparatus is protected by thewafer 8. In this position, the primary conduit 1 is flushed with a hot sterilising liquid or with some sterilising gas so as to make the primary conduit 1 sterile and maintain its sterility. After sterilising of the primary conduit 1, as shown in Fig. 2, theclosing sleeve 16 is closed, whereupon theinner part 17 is pulled backwards with the aid of said means 7 so that a free volume forms in the upper part of thevalve member 18. Since in this position thecircumferential groove 5 is uncovered, the upper part of thevalve member 18 is sterilised together with thecircumferential groove 5 by using a sterilising agent in the form of liquid or gas supplied through the connectingtubes 4. - In Fig. 3, the closing
sleeve 16 is again raised and theinner part 17 is once more in its upper position. To enable the secondary liquid to be supplied, the position of thesupply tube 12 is raised so that thecutting edge 20 of thetube 12 ruptures theprotective wafer 8. The apparatus is now ready to be used and the primary liquid is supplied through the primary conduit 1 while at the same time feeding the previously mentioned secondary liquid, which is controlled by the flowing amount of the primary liquid. By the sterilising liquid or gas being continuously supplied through the connectingtubes 4, it is possible to maintain sterility in the apparatus. - Fig. 4 shows how the apparatus is stopped without sterility being lost. The stopping occurs simply by the closing
sleeve 16 being lowered towards thevalve member 18 so that the supply of secondary and primary liquid is stopped. In this manner, the apparatus can be switched off for a long period without necessitating the starting of a new sterilising programme. - Fig. 5 shows how the connecting devices to the dosing apparatus can be arranged. Fig. a) shows the connecting device before being fixed on the dosing apparatus. The
inner part 17 with its appliedprotective wafer 8 and its packing rings 6 has already been described. It is evident from the Figure that theinner part 17 with thesupply tube 12 can be connected, by means of ascrew connection 23, to adistribution tube 25 whose opposite end can also have a tight protective wafer to be connected to a sterile tank for secondary liquid. Fig. b) shows a smaller type of connecting device intended to be used when adding very small amounts of secondary liquid, and Fig. c) shows protective sleeves which can be used to cover the contact surfaces of the not yet used connecting means. - It has been found convenient to pre-treat the
distribution tube 25 by sterilisation as shown in Fig. 5 in such manner that it is provided with itsprotective sleeves 10, and that thedistribution tube 25 in its assembled state is then exposed to sterilising gamma radiation which sterilises thedistribution tube 25, inside and outside, and the parts included in thedistribution tube 25. If desired, thedistribution tube 25 can, before the sterilising treatment, be packaged in a sealed plastic bag, but as a rule it is sufficient to use theprotective sleeves 10 shown in Fig. 5 as an aseptic seal of thedistribution tube 25. - Fig. 6 shows a second preferred embodiment of the dosing apparatus according to the invention. What differs this embodiment from the above first embodiment of the present invention is that the means for rupturing the
protective wafer 8 in this case consists of aprojection 24 arranged on theclosing sleeve 16. - By moving the
closing sleeve 16 and theinner part 17 together, i.e. by arranging theclosing sleeve 16 in its closed position and by displacing theinner part 17 in the direction of theclosing sleeve 16, theprojection 24 is made to engage theprotective wafer 8 and, thus, penetrate the same. Thesupply tube 12 can then be inserted through the thus formed opening 9 to allow injection of the secondary sterile liquid into the primary sterile liquid flowing in the primary conduit 1. - It has been found that the preferred embodiments of the inventive dosing apparatus operate well and that excellent results have been achieved when packaging aseptic liquid mixtures.
Claims (10)
- A dosing apparatus for continuous injection of a small amount of secondary sterile liquid into a free-flowing primary sterile liquid, characterised in    that the dosing apparatus has a controllable valve with a movable closing sleeve (16) for controlling the supply of secondary sterile liquid to the flowing sterile primary liquid,
   that the dosing apparatus has an outer valve member (18) which in itself comprises an inner part (17) which is displaceable in relation to the valve member (18) and has a recess or duct (19) whose end facing the closing sleeve (16) is covered with a sealing protective wafer (8),
   that a supply tube (12) for supplying secondary sterile liquid is arranged in said recess or duct (19), and
   that the dosing apparatus has a means (12; 24) for rupturing the protective wafer (8) to allow said injection of the secondary sterile liquid into the primary sterile liquid through the supply tube (12). - A dosing apparatus as claimed in claim 1, characterised in that the supply tube (12) is adjustable longitudinally to allow insertion of the supply tube (12) through an opening (9) in the protective wafer (8) provided by the means (12;24) for rupturing the protective wafer (8).
- A dosing apparatus as claimed in claim 2, characterised in that the inner part (17), with the aid of tight, positionable connecting means (11), is aseptically connectable to the longitudinally adjustable supply tube (12), which in turn is connectable to a storage container and feeding device for said secondary sterile liquid.
- A dosing apparatus as claimed in any one of claims 1-3, characterised in that the means (24) for rupturing the protective wafer (8) comprises a projection (24), which is arranged on the closing sleeve (16) and which, by moving the closing sleeve (16) and the inner part (17) together, is adapted to engage and thus rupture the protective wafer (8) to form an opening (9).
- A dosing apparatus as claimed in any one of claims 2-3, characterised in that the longitudinally adjustable supply tube (12) forms said means (12) for rupturing the protective wafer (8), said supply tube (12) being adapted to penetrate the protective wafer (8) to form an opening (9) by moving the supply tube (12) in the direction of the protective wafer (8).
- A dosing apparatus as claimed in claim 5, characterised in that the longitudinally adjustable supply tube (12), which is controllably movably arranged in the recess (19) in the inner part (17), is at its end facing away from the closing sleeve (16) connected to a sealing bellow-shaped, positionable connecting means (11), that the inner part (17) at its end facing the closing sleeve (16) has a sealing protective wafer (8) in the form of a membrane of plastic, rubber or a similar material, the opening (20) of the longitudinally adjustable supply tube (12) being formed as a cutting edge for rupturing the protective wafer (8) to form an opening (9).
- A dosing apparatus as claimed in any one of the preceding claims, characterised in that the outer valve member (18) has an inner groove or gap (5), which by means of connecting tubes (4) is connectable to a storage of sterilising material, that the inner part (17) supported in the outer valve member (18) forms by means of packing rings (6) a closed part round the groove (5) to guide the flow of sterilising material, which is supplied and preferably discharged through the connecting tubes (4).
- A dosing apparatus as claimed in claim 1, characterised in that the protective wafer (8) included in the apparatus is made of a plastic or rubber material which should withstand a temperature of 140°C and an excess pressure of 2 bar.
- A dosing apparatus as claimed in claim 7, characterised in that the inner part (17) is displaceable within the valve member (18) to an area below the groove or gap (5), that sterile liquid or vapour is supplied to a space above the inner part (17), the exposed part of the inner surface of the valve member (18), the inner surface of the closed closing sleeve (16) and the protective wafer (8) of the inner part (17) forming said space which is treated with said sterilising liquid or with vapour supplied through the connecting tubes (4).
- A method of using the dosing apparatus as claimed in any one of the preceding claims, characterised in thata) an internal sterile dosing apparatus provided with a fixed protective wafer (8) is mounted on a primary conduit (1),b) a flow of sterilising material, such as vapour or sterilising gas or liquid, is passed through connecting tubes (4) and is made to fill the space in the uncovered portion of the inner part (17) which at the top is closed by an inner closing sleeve (16) and at the bottom is closed by the inner part (17) retracted into the outer valve member (18), said outer valve member (18) having an inner groove or gap (5), which by means of connecting tubes (4) is connectable to a storage of sterilising material,c) that the inner part (17) is raised so that a portion of the inner part (17) surrounded by packing rings (6) is located in front of the opening parts of the connecting tubes (4) and the groove or gap (5), and that a sterilising material is passed through the connecting tubes (4) and the groove (5) to ensure aseptic sealing between the outer part or valve member (18) and the movable inner part (17),d) that the means (12; 24) for rupturing the protective wafer (8) is made to penetrate the protective wafer (8) to form an opening (9),e) that the movable closing sleeve (16) is raised, andf) that sterile secondary liquid which is supplied through the supply tube (12) and adjusted in respect of volume is conducted into the primary conduit (1) through the opening (9) for mixing with the sterile primary liquid flowing in the primary conduit (1).
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9801615 | 1998-05-11 | ||
SE9801615A SE512503C2 (en) | 1998-05-11 | 1998-05-11 | Dosing nozzle for continuous injection of a small amount of sterile, secondary fluid into a free-flowing sterile, primary fluid and ways of using the dosing nozzle |
PCT/SE1999/000787 WO1999058234A1 (en) | 1998-05-11 | 1999-05-10 | Dosing apparatus for continuous injection of a preferably small amount of secondary sterile liquid into a free-flowing primary component of sterile liquid |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1083983A1 EP1083983A1 (en) | 2001-03-21 |
EP1083983B1 true EP1083983B1 (en) | 2003-01-02 |
Family
ID=20411236
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP99927045A Expired - Lifetime EP1083983B1 (en) | 1998-05-11 | 1999-05-10 | Dosing apparatus and method for continuous injection of a preferably small amount of secondary sterile liquid into a free-flowing primary component of sterile liquid |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1083983B1 (en) |
AT (1) | ATE230297T1 (en) |
AU (1) | AU4403899A (en) |
DE (1) | DE69904719T2 (en) |
DK (1) | DK1083983T3 (en) |
ES (1) | ES2188180T3 (en) |
SE (1) | SE512503C2 (en) |
WO (1) | WO1999058234A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102010028572A1 (en) * | 2010-05-05 | 2011-11-10 | Voith Patent Gmbh | Method for admixing a liquid chemical to a process stream and apparatus |
DE102011007274A1 (en) * | 2011-04-13 | 2012-10-18 | Voith Patent Gmbh | Method and nozzle arrangement for introducing chemicals and / or additives into a process stream of a production process |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE506791C2 (en) * | 1996-06-03 | 1998-02-09 | Arom Pak Ab | Dosage device for mixing a flowing primary liquid with one or more secondary liquids and a method for mixing two or more liquids in a continuous process |
-
1998
- 1998-05-11 SE SE9801615A patent/SE512503C2/en not_active IP Right Cessation
-
1999
- 1999-05-10 WO PCT/SE1999/000787 patent/WO1999058234A1/en active IP Right Grant
- 1999-05-10 AT AT99927045T patent/ATE230297T1/en active
- 1999-05-10 EP EP99927045A patent/EP1083983B1/en not_active Expired - Lifetime
- 1999-05-10 DK DK99927045T patent/DK1083983T3/en active
- 1999-05-10 AU AU44038/99A patent/AU4403899A/en not_active Abandoned
- 1999-05-10 DE DE69904719T patent/DE69904719T2/en not_active Expired - Lifetime
- 1999-05-10 ES ES99927045T patent/ES2188180T3/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
SE512503C2 (en) | 2000-03-27 |
WO1999058234A1 (en) | 1999-11-18 |
AU4403899A (en) | 1999-11-29 |
SE9801615D0 (en) | 1998-05-11 |
ATE230297T1 (en) | 2003-01-15 |
ES2188180T3 (en) | 2003-06-16 |
DK1083983T3 (en) | 2003-04-22 |
DE69904719D1 (en) | 2003-02-06 |
SE9801615L (en) | 1999-11-12 |
DE69904719T2 (en) | 2003-09-18 |
EP1083983A1 (en) | 2001-03-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1182269A (en) | Aseptic filling station | |
US2930170A (en) | Means and method for aseptic packaging | |
AU626056B2 (en) | Valve assembly | |
FI87441B (en) | FOERFARANDE OCH ANORDNING FOER ASEPTISK FYLLNING AV EN FOERPACKNING MED VAETSKA. | |
AU704185B2 (en) | Apparatus for mixing a fluid and a liquid | |
US4623516A (en) | Sterilizing method for an encapsulating machine | |
NZ515905A (en) | Dip tube device for introducing a predetermined dose of additive into a packaged liquid | |
EP0072699B1 (en) | Method and system for aseptically filling a container with fluid | |
AU2018392834A1 (en) | Method for filling a thin-body flexible bag provided with a spout | |
US7021032B2 (en) | Tube-filling machine and a method for tube end sealing in such a machine | |
EP1083983B1 (en) | Dosing apparatus and method for continuous injection of a preferably small amount of secondary sterile liquid into a free-flowing primary component of sterile liquid | |
EP0796792B1 (en) | Method for sterile packing of a substance | |
US6543495B2 (en) | Multiple access container and methods for the transfer of fluent materials | |
US3020689A (en) | Method and apparatus for the continuous filling of plastic tubing with sterile liquids | |
MX2007009214A (en) | An integrated fitment for aseptic packaging. | |
JP5153786B2 (en) | Apparatus and method for refilling powders and solids while preventing contamination, and novel use of weldable and peelable tubular film | |
AU8259187A (en) | A method and an arrangement for a filling valve in a packing machine | |
US20190248525A1 (en) | A method and apparatus for manufacturing a double bag | |
US20040139704A1 (en) | Apparatus and method for aseptically filling a container | |
US6267153B1 (en) | Process for filling containers simultaneously with their sterilization | |
JP7121339B2 (en) | Chamber sterilization set and closure for chamber sterilization, and sterile filling apparatus and method | |
WO2002085728A1 (en) | Apparatus and method for aseptically filling a container | |
WO2024024210A1 (en) | Liquid filling apparatus | |
AU2015297057A1 (en) | Detachable dispensing system for bottled liquid | |
JPH0710686B2 (en) | Aseptic filling method of fluid into bag |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20001110 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: AROM PAK INTERNATIONAL AB |
|
RTI1 | Title (correction) |
Free format text: DOSING APPARATUS AND METHOD FOR CONTINUOUS INJECTION OF A PREFERABLY SMALL AMOUNT OF SECONDARY STERILE LIQUID INTO A FREE-FLOWING PRIMARY COMPONENT OF STERILE LIQUID |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20030102 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20030102 Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20030102 |
|
REF | Corresponds to: |
Ref document number: 230297 Country of ref document: AT Date of ref document: 20030115 Kind code of ref document: T |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D Free format text: 20030102 |
|
RAP2 | Party data changed (patent owner data changed or rights of a patent transferred) |
Owner name: TETRA LAVAL HOLDINGS & FINANCE S.A. |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REF | Corresponds to: |
Ref document number: 69904719 Country of ref document: DE Date of ref document: 20030206 Kind code of ref document: P |
|
NLT2 | Nl: modifications (of names), taken from the european patent patent bulletin |
Owner name: TETRA LAVAL HOLDINGS & FINANCE S.A. |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: NV Representative=s name: PATENTANWAELTE FELDMANN & PARTNER AG |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20030402 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20030402 |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: T3 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20030510 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20030510 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20030512 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20030531 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2188180 Country of ref document: ES Kind code of ref document: T3 |
|
ET | Fr: translation filed | ||
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20031003 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PFA Owner name: TETRA LAVAL HOLDINGS & FINANCE S.A. Free format text: TETRA LAVAL HOLDINGS & FINANCE S.A.#AVENUE GENERAL-GUISAN 70#1009 PULLY (CH) -TRANSFER TO- TETRA LAVAL HOLDINGS & FINANCE S.A.#AVENUE GENERAL-GUISAN 70#1009 PULLY (CH) |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 18 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 19 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 20170512 Year of fee payment: 19 Ref country code: DK Payment date: 20170510 Year of fee payment: 19 Ref country code: GB Payment date: 20170510 Year of fee payment: 19 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: AT Payment date: 20170425 Year of fee payment: 19 Ref country code: FI Payment date: 20170509 Year of fee payment: 19 Ref country code: IT Payment date: 20170522 Year of fee payment: 19 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20180424 Year of fee payment: 20 Ref country code: ES Payment date: 20180605 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20180411 Year of fee payment: 20 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: EBP Effective date: 20180531 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MM01 Ref document number: 230297 Country of ref document: AT Kind code of ref document: T Effective date: 20180510 |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20180510 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180510 Ref country code: FI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180510 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180531 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180531 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180510 Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180510 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R071 Ref document number: 69904719 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180531 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20200724 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20190511 |